Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Home Explore Peptides Deep Research Latest News
Recovery Longevity Cognitive Body Composition Sexual Wellness Sleep & Circadian Immune
Joint & Tissue Repair Fat Loss & Metabolism Skin Rejuvenation Muscle Recovery Anti-Aging & Longevity Cognitive Focus Anxiety & Calm Sleep Optimization
Overview Peptide Therapy Thailand What Are Peptides Guides Peptide Quality Standards Research vs Clinical Grade Dosage Guide How to Reconstitute Storage Guide Thailand Guide Choosing a Provider Compounding Lab Safety Comparisons BPC-157 vs TB-500 Semax vs Selank CJC-1295 vs Tesamorelin AOD-9604 vs MOTS-c Epithalon vs GHK-Cu
Speak with a Specialist About
LIBRARY // COMPOUND INDEX

Peptide Compound Library

Explore detailed profiles for every compound in the Peptide Science Thailand library. Each entry includes mechanism of action, research summaries, evidence grading, and referenced data.

Showing 50 compounds

All Compounds

Pen
Oral
Recovery

BPC-157

Body Protection Compound, Accelerating Tissue Repair at the Molecular Level

Peer-reviewed References
Read Profile

BPC-157

Body Protection Compound, Accelerating Tissue Repair at the Molecular Level

Research Focus Areas
  • Accelerated Tissue Healing
  • Gastric Cytoprotection
  • Anti-Inflammatory Action
  • Neuroprotective Properties
Dosages in Published Literature
Protocol250-500mcg per day
RouteSubcutaneous injection
Duration4-6 weeks per cycle
Read Profile
Pen
Longevity

CJC-1295 / Ipamorelin

Synergistic Growth Hormone Optimization, Amplifying Natural GH Pulsatility

Peer-reviewed References
Read Profile

CJC-1295 / Ipamorelin

Synergistic Growth Hormone Optimization, Amplifying Natural GH Pulsatility

Research Focus Areas
  • Enhanced Growth Hormone Output
  • Selective Hormone Profile
  • Body Composition Support
  • Recovery & Longevity Support
Dosages in Published Literature
Protocol100mcg CJC-1295 + 100mcg Ipamorelin
RouteSubcutaneous injection
Duration8-12 weeks per cycle
Read Profile
Nasal
Cognitive

Semax

Neurogenic Peptide, BDNF Upregulation for Cognitive Enhancement

Peer-reviewed References
Read Profile

Semax

Neurogenic Peptide, BDNF Upregulation for Cognitive Enhancement

Research Focus Areas
  • Cognitive Enhancement
  • Neuroprotection
  • Memory & Learning Support
  • Mood Stabilization
Dosages in Published Literature
Protocol200-600mcg per day
RouteIntranasal administration
Duration10-20 day cycles
Read Profile
Pen
Recovery

TB-500

Thymosin Beta-4, Cell Migration and Universal Tissue Repair

Peer-reviewed References
Read Profile

TB-500

Thymosin Beta-4, Cell Migration and Universal Tissue Repair

Research Focus Areas
  • Universal Tissue Repair
  • Potent Anti-Inflammatory Action
  • Reduced Scar Formation
  • Enhanced Angiogenesis
Dosages in Published Literature
Protocol2-2.5mg administered subcutaneously twice weekly during loading phase
RouteSubcutaneous injection
Duration4-6 weeks loading, 2-4 weeks maintenance
Read Profile
Pen
Longevity

MOTS-c

Mitochondrial-Derived Peptide, AMPK Activation for Metabolic Optimization

Peer-reviewed References
Read Profile

MOTS-c

Mitochondrial-Derived Peptide, AMPK Activation for Metabolic Optimization

Research Focus Areas
  • Metabolic Optimization
  • Exercise Capacity Enhancement
  • Longevity-Associated Signaling
  • Mitochondrial Function Support
Dosages in Published Literature
Protocol5-10mg administered subcutaneously 3 times weekly
RouteSubcutaneous injection
Duration4-8 weeks per cycle
Read Profile
Nasal
Cognitive

Selank

Anxiolytic Nootropic, GABAergic Modulation for Calm Focus

Peer-reviewed References
Read Profile

Selank

Anxiolytic Nootropic, GABAergic Modulation for Calm Focus

Research Focus Areas
  • Anxiolysis Without Sedation
  • Preserved Cognitive Function
  • Immune System Modulation
  • No Dependence or Tolerance
Dosages in Published Literature
Protocol250-500mcg per day
RouteIntranasal administration
Duration14-21 day cycles
Read Profile
Pen
Body Composition

Tesamorelin

GHRH Analogue, Targeted Visceral Fat Reduction via Pulsatile GH Release

Peer-reviewed References
Read Profile

Tesamorelin

GHRH Analogue, Targeted Visceral Fat Reduction via Pulsatile GH Release

Research Focus Areas
  • Clinically Proven Visceral Fat Reduction
  • Improved Lipid Profile
  • Cognitive Function Support
  • Physiological GH Optimization
Dosages in Published Literature
Protocol1-2mg administered subcutaneously once daily
RouteSubcutaneous injection
Duration8-12 weeks per cycle
Read Profile
Pen
Nasal
Sexual Wellness

PT-141 (Bremelanotide)

Melanocortin Receptor Agonist, Central Nervous System Approach to Sexual Function

Peer-reviewed References
Read Profile

PT-141 (Bremelanotide)

Melanocortin Receptor Agonist, Central Nervous System Approach to Sexual Function

Research Focus Areas
  • Central Mechanism of Action
  • FDA-Approved Efficacy
  • PDE5 Non-Responder Option
  • Holistic Sexual Response
Dosages in Published Literature
Protocol1-2mg administered subcutaneously approximately 45 minutes before anticipated sexual activity
RouteSubcutaneous injection
DurationAs needed, not more than once every 24 hours, and no more than 8 doses per month
Read Profile
Pen
Sleep & Circadian

DSIP

Delta Sleep Inducing Peptide, Natural Sleep Architecture Optimization

Peer-reviewed References
Read Profile

DSIP

Delta Sleep Inducing Peptide, Natural Sleep Architecture Optimization

Research Focus Areas
  • Enhanced Delta Sleep
  • Cortisol Regulation
  • Non-Sedative Sleep Improvement
  • Stress Resilience
Dosages in Published Literature
Protocol100-300mcg administered subcutaneously 30-60 minutes before bedtime
RouteSubcutaneous injection
Duration5-10 days on, 5 days off cycling
Read Profile
Body Composition

AOD-9604

GH Fragment 176-191, Targeted Lipolysis Without Hormonal Side Effects

Peer-reviewed References
Read Profile

AOD-9604

GH Fragment 176-191, Targeted Lipolysis Without Hormonal Side Effects

Research Focus Areas
  • Targeted Lipolysis
  • No Hormonal Side Effects
  • Lipogenesis Prevention
  • FDA GRAS Safety Status
Dosages in Published Literature
Protocol300mcg administered subcutaneously once daily
RouteSubcutaneous injection
Duration12-20 weeks per cycle
Read Profile
Longevity

Epithalon

Telomerase Activator, The Longevity Peptide from Pineal Research

Peer-reviewed References
Read Profile

Epithalon

Telomerase Activator, The Longevity Peptide from Pineal Research

Research Focus Areas
  • Telomerase Activation
  • Melatonin Restoration
  • Lifespan Extension in Models
  • Antioxidant Defense Enhancement
Dosages in Published Literature
Protocol5-10mg administered subcutaneously once daily
RouteSubcutaneous injection
Duration10-20 day cycles, typically repeated 2 times per year
Read Profile
Pen
Recovery

GHK-Cu

Copper Peptide Complex, 4,000+ Gene Modulator for Regeneration

Peer-reviewed References
Read Profile

GHK-Cu

Copper Peptide Complex, 4,000+ Gene Modulator for Regeneration

Research Focus Areas
  • Unprecedented Gene Modulation
  • Collagen & Skin Regeneration
  • Scarless Healing Promotion
  • Antioxidant & Anti-Inflammatory
Dosages in Published Literature
Protocol1-2mg administered subcutaneously daily; also used topically in dermatological applications
RouteSubcutaneous injection or topical application
Duration4-8 weeks for systemic use; ongoing for topical applications
Read Profile
Cognitive

Cerebrolysin

Neurotrophic Peptide Complex, Supporting Neuronal Plasticity and Cognitive Function

Peer-reviewed References
Read Profile

Cerebrolysin

Neurotrophic Peptide Complex, Supporting Neuronal Plasticity and Cognitive Function

Research Focus Areas
  • Neurotrophic Support
  • Synaptic Plasticity Enhancement
  • Neuroprotection Against Excitotoxicity
  • Neurogenesis Promotion
Dosages in Published Literature
ProtocolDosage varies significantly based on research context; typical preclinical protocols use weight-based dosing administered intramuscularly or intravenously
RouteIntramuscular or intravenous injection
Duration10-20 day treatment courses, protocol dependent
Read Profile
Pen
Immune

Thymosin Alpha-1

Thymic Peptide Immunomodulator, Restoring Adaptive Immune Surveillance

Peer-reviewed References
Read Profile

Thymosin Alpha-1

Thymic Peptide Immunomodulator, Restoring Adaptive Immune Surveillance

Research Focus Areas
  • Adaptive Immune Enhancement
  • Innate Immune Activation
  • Balanced Immunomodulation
  • Vaccine Adjuvant Potential
Dosages in Published Literature
Protocol1.6mg administered subcutaneously
RouteSubcutaneous injection
DurationTreatment courses of 2-6 months depending on clinical context
Read Profile
Recovery

Thymosin Beta-4

Universal Actin-Sequestering Peptide, Orchestrating Cellular Migration and Tissue Repair

Peer-reviewed References
Read Profile

Thymosin Beta-4

Universal Actin-Sequestering Peptide, Orchestrating Cellular Migration and Tissue Repair

Research Focus Areas
  • Accelerated Wound Healing
  • Anti-Inflammatory Action
  • Cardioprotection
  • Muscle Repair & Satellite Cell Activation
Dosages in Published Literature
Protocol2-5mg administered subcutaneously
RouteSubcutaneous injection
Duration4-8 weeks per cycle depending on tissue repair objectives
Read Profile
Recovery

LL-37

Human Cathelicidin Antimicrobial Peptide, Bridging Innate Defense and Tissue Regeneration

Peer-reviewed References
Read Profile

LL-37

Human Cathelicidin Antimicrobial Peptide, Bridging Innate Defense and Tissue Regeneration

Research Focus Areas
  • Broad-Spectrum Antimicrobial Defense
  • Wound Healing Promotion
  • Anti-Biofilm Activity
  • Immunomodulatory Bridge Function
Dosages in Published Literature
Protocol100-300mcg administered subcutaneously
RouteSubcutaneous injection
Duration2-6 weeks per cycle
Read Profile
Longevity

Humanin

Mitochondrial-Derived Cytoprotective Peptide, Defending Cellular Integrity Against Age-Related Decline

Peer-reviewed References
Read Profile

Humanin

Mitochondrial-Derived Cytoprotective Peptide, Defending Cellular Integrity Against Age-Related Decline

Research Focus Areas
  • Potent Cytoprotection
  • Neuroprotection
  • Metabolic Regulation
  • Longevity Association
Dosages in Published Literature
ProtocolResearch protocols typically use weight-based dosing; preclinical studies commonly employ 1-4mg/kg in animal models. Human-equivalent dosing is determined by specialist assessment
RouteSubcutaneous or intraperitoneal injection (research context dependent)
DurationProtocol dependent, typically 4-12 weeks in preclinical studies
Read Profile
Sexual Wellness

Kisspeptin

Hypothalamic Neuropeptide, Master Regulator of Reproductive Endocrine Axis

Peer-reviewed References
Read Profile

Kisspeptin

Hypothalamic Neuropeptide, Master Regulator of Reproductive Endocrine Axis

Research Focus Areas
  • HPG Axis Activation
  • Physiological Gonadotropin Pattern
  • Neuroendocrine-Behavioral Integration
  • Metabolic Integration
Dosages in Published Literature
ProtocolDosing varies by clinical research context; typical protocols use 1-10nmol/kg (Kisspeptin-10) or weight-adjusted doses of Kisspeptin-54
RouteSubcutaneous or intravenous injection
DurationSingle-dose diagnostic protocols or short-term treatment courses of days to weeks depending on application
Read Profile
Pen
Sexual Wellness

Melanotan-2

Synthetic Alpha-MSH Analog, Modulating Melanocortin Receptor Signaling

Peer-reviewed References
Read Profile

Melanotan-2

Synthetic Alpha-MSH Analog, Modulating Melanocortin Receptor Signaling

Research Focus Areas
  • Melanocortin-Mediated Pigmentation
  • Central Sexual Function Modulation
  • Appetite and Energy Regulation
  • Photoprotective Potential
Dosages in Published Literature
ProtocolInitial loading phase of 0.25mg per day
RouteSubcutaneous injection
DurationLoading phase of 2-4 weeks, followed by maintenance dosing at reduced frequency
Read Profile
Cognitive

VIP (Vasoactive Intestinal Peptide)

Neuroprotective Vasoactive Peptide, Modulating Neuroimmune and Vascular Function

Peer-reviewed References
Read Profile

VIP (Vasoactive Intestinal Peptide)

Neuroprotective Vasoactive Peptide, Modulating Neuroimmune and Vascular Function

Research Focus Areas
  • Neuroprotection and Neurotrophic Support
  • Anti-Inflammatory Immune Modulation
  • Circadian Rhythm Regulation
  • Pulmonary and Vascular Function
Dosages in Published Literature
Protocol50-200mcg per day
RouteSubcutaneous injection
DurationVariable, typically 4-12 weeks depending on the research protocol
Read Profile
Oral
Cognitive

Dihexa

Hexapeptide Analog, Potent Hepatocyte Growth Factor Pathway Modulator

Peer-reviewed References
Read Profile

Dihexa

Hexapeptide Analog, Potent Hepatocyte Growth Factor Pathway Modulator

Research Focus Areas
  • Synaptogenic Neurotrophic Activity
  • Cognitive Enhancement at Low Doses
  • Oral Bioavailability
  • Structural Neuroplasticity Promotion
Dosages in Published Literature
Protocol10-20mg per day orally
RouteOral or subcutaneous injection
DurationResearch protocols typically span 4-8 weeks
Read Profile
Oral
Body Composition

5-Amino-1MQ

NNMT Inhibitor, Targeting Cellular Energy Metabolism and Fat Regulation

Peer-reviewed References
Read Profile

5-Amino-1MQ

NNMT Inhibitor, Targeting Cellular Energy Metabolism and Fat Regulation

Research Focus Areas
  • Enhanced Cellular Energy Expenditure
  • NAD+ Biosynthesis Support
  • Epigenetic Metabolic Regulation
  • Non-Hormonal, Non-Stimulant Mechanism
Dosages in Published Literature
Protocol50-150mg per day orally
RouteOral administration (capsule) or subcutaneous injection
DurationResearch protocols typically span 4-8 weeks
Read Profile
Oral
Body Composition

Tesofensine

Triple Monoamine Reuptake Inhibitor, Modulating Appetite and Metabolic Signaling

Peer-reviewed References
Read Profile

Tesofensine

Triple Monoamine Reuptake Inhibitor, Modulating Appetite and Metabolic Signaling

Research Focus Areas
  • Clinically Demonstrated Weight Reduction
  • Appetite Regulation Through Central Mechanisms
  • Metabolic Rate Enhancement
  • Cardiometabolic Risk Factor Improvement
Dosages in Published Literature
Protocol0.25-0.5mg per day orally
RouteOral administration (capsule)
DurationClinical trials evaluated 24-week administration periods
Read Profile
Oral
Body Composition

DHH-B (Dihydrohonokiol-B)

GABA-A Receptor Modulator, Bioactive Honokiol Derivative for Stress and Metabolic Research

Peer-reviewed References
Read Profile

DHH-B (Dihydrohonokiol-B)

GABA-A Receptor Modulator, Bioactive Honokiol Derivative for Stress and Metabolic Research

Research Focus Areas
  • Selective Anxiolytic Activity
  • Stress-Metabolism Axis Research
  • Antioxidant and Cytoprotective Properties
  • Oral Bioavailability and CNS Penetration
Dosages in Published Literature
Protocol100-300mg per day orally
RouteOral administration (capsule)
DurationResearch protocols typically span 4-8 weeks
Read Profile
Oral
Cognitive

Noopept

Cycloprolylglycine-Derived Nootropic, Enhancing Neuroplasticity and Cognitive Function

Peer-reviewed References
Read Profile

Noopept

Cycloprolylglycine-Derived Nootropic, Enhancing Neuroplasticity and Cognitive Function

Research Focus Areas
  • Enhanced Memory and Learning
  • Neuroprotective Activity
  • Anti-Neuroinflammatory Effects
  • Anxiolytic Properties
Dosages in Published Literature
Protocol10-30mg per day
RouteOral or sublingual administration; injectable formulations are also used in research settings
Duration1.5-3 month cycles
Read Profile
Oral
Body Composition

MK-677 (Ibutamoren)

Non-Peptide Growth Hormone Secretagogue, Amplifying Endogenous GH and IGF-1 Output

Peer-reviewed References
Read Profile

MK-677 (Ibutamoren)

Non-Peptide Growth Hormone Secretagogue, Amplifying Endogenous GH and IGF-1 Output

Research Focus Areas
  • Sustained Growth Hormone Elevation
  • Improved Body Composition
  • Enhanced Sleep Quality
  • Bone Metabolism Support
Dosages in Published Literature
Protocol10-25mg per day
RouteOral administration
Duration8-12 week cycles, with some research protocols extending to 12 months
Read Profile
Oral
Body Composition

LGD-4033 (Ligandrol)

Selective Androgen Receptor Modulator, Targeting Muscle and Bone with Tissue Selectivity

Peer-reviewed References
Read Profile

LGD-4033 (Ligandrol)

Selective Androgen Receptor Modulator, Targeting Muscle and Bone with Tissue Selectivity

Research Focus Areas
  • Lean Mass Accretion
  • Tissue-Selective Androgen Activity
  • Bone Mineral Density Support
  • Oral Bioavailability and Convenience
Dosages in Published Literature
Protocol1-10mg per day
RouteOral administration
Duration6-8 week cycles
Read Profile
Oral
Longevity

NMN (Nicotinamide Mononucleotide)

NAD+ Precursor Nucleotide, Restoring Cellular Energy Metabolism and Sirtuin Activity

Peer-reviewed References
Read Profile

NMN (Nicotinamide Mononucleotide)

NAD+ Precursor Nucleotide, Restoring Cellular Energy Metabolism and Sirtuin Activity

Research Focus Areas
  • NAD+ Level Restoration
  • Mitochondrial Function Enhancement
  • Metabolic and Insulin Sensitivity Support
  • Vascular and Cardiovascular Health
Dosages in Published Literature
Protocol250-500mg per day
RouteOral administration; sublingual and injectable formulations also studied
DurationContinuous daily supplementation in most research protocols (12 weeks to 12 months studied)
Read Profile
Oral
Body Composition

GW1516 (Cardarine)

PPAR-Delta Agonist, Reprogramming Metabolic Substrate Utilization and Endurance Capacity

Peer-reviewed References
Read Profile

GW1516 (Cardarine)

PPAR-Delta Agonist, Reprogramming Metabolic Substrate Utilization and Endurance Capacity

Research Focus Areas
  • Enhanced Endurance Capacity
  • Improved Lipid Profiles
  • Fat Metabolism Activation
  • Anti-Inflammatory Metabolic Effects
Dosages in Published Literature
Protocol10-20mg per day
RouteOral administration
Duration6-8 week cycles in research settings
Read Profile
Oral
Recovery

KPV

Alpha-MSH Derived Tripeptide, Modulating Inflammatory Cascades at the Cellular Level

Peer-reviewed References
Read Profile

KPV

Alpha-MSH Derived Tripeptide, Modulating Inflammatory Cascades at the Cellular Level

Research Focus Areas
  • Potent Anti-Inflammatory Activity
  • Gastrointestinal Mucosal Protection
  • Selective Anti-Inflammatory Action
  • Antimicrobial and Wound Healing Properties
Dosages in Published Literature
Protocol200-500mcg per day
RouteSubcutaneous injection or oral administration
Duration4-8 weeks per cycle
Read Profile
Nasal
Sexual Wellness

Oxytocin

The Bonding Neuropeptide, Modulating Social Cognition and Reproductive Physiology

Peer-reviewed References
Read Profile

Oxytocin

The Bonding Neuropeptide, Modulating Social Cognition and Reproductive Physiology

Research Focus Areas
  • Social Cognition Enhancement
  • Anxiolytic & Stress-Buffering Effects
  • Reproductive Function Support
  • Metabolic Regulation
Dosages in Published Literature
Protocol20-40 IU intranasally per administration
RouteIntranasal spray or subcutaneous injection
DurationVariable by protocol, typically 4-8 weeks in clinical studies
Read Profile
Nasal
Cognitive

PE-22-28

Neurotrophic Heptapeptide, Enhancing BDNF-Mediated Cognitive Resilience

Peer-reviewed References
Read Profile

PE-22-28

Neurotrophic Heptapeptide, Enhancing BDNF-Mediated Cognitive Resilience

Research Focus Areas
  • Cognitive Function Enhancement
  • Hippocampal Neurogenesis Promotion
  • Neurotrophic Factor Upregulation
  • Serotonergic Tone Enhancement
Dosages in Published Literature
Protocol100-500mcg per day
RouteIntranasal spray or subcutaneous injection
Duration4-8 weeks per cycle in preclinical protocols
Read Profile
Pen
Body Composition

Ipamorelin

Selective GH Secretagogue, Precision Growth Hormone Pulse Stimulation

Peer-reviewed References
Read Profile

Ipamorelin

Selective GH Secretagogue, Precision Growth Hormone Pulse Stimulation

Research Focus Areas
  • Selective GH Stimulation
  • Body Composition Optimization
  • Bone Mineral Density Support
  • Recovery & Tissue Repair
Dosages in Published Literature
Protocol200-300mcg per administration
RouteSubcutaneous injection
Duration8-12 weeks per cycle
Read Profile
Topical
Recovery

PTD-DBM + Valproic Acid

Hair Follicle Regeneration Complex, Activating Wnt/Beta-Catenin Signaling for Dermal Papilla Restoration

Peer-reviewed References
Read Profile

PTD-DBM + Valproic Acid

Hair Follicle Regeneration Complex, Activating Wnt/Beta-Catenin Signaling for Dermal Papilla Restoration

Research Focus Areas
  • Wnt/Beta-Catenin Pathway Reactivation
  • Dermal Papilla Inductivity Restoration
  • Hair Follicle Cycling Modulation
  • Targeted Topical Delivery
Dosages in Published Literature
ProtocolApply topically to affected scalp areas once daily
RouteTopical application
Duration12-24 weeks minimum for observable effects in preclinical models
Read Profile
Topical
Longevity

GHK-Cu + Zinc Thymulin (Duo)

Dual Regenerative Complex, Synergistic Skin Matrix Remodeling and Follicle Vitality

Peer-reviewed References
Read Profile

GHK-Cu + Zinc Thymulin (Duo)

Dual Regenerative Complex, Synergistic Skin Matrix Remodeling and Follicle Vitality

Research Focus Areas
  • Comprehensive Skin Matrix Remodeling
  • Hair Follicle Cycle Optimization
  • Anti-Inflammatory & Antioxidant Protection
  • DHT Modulation
Dosages in Published Literature
ProtocolApply 4-6 drops to target area once or twice daily
RouteTopical application
DurationMinimum 12-16 weeks for skin improvements, 16-24 weeks for hair-related effects
Read Profile
Topical
Longevity

GHK-Cu + Argireline + Leuphasyl (Trio)

Triple-Action Anti-Aging Complex, Targeting Matrix Renewal, Neuromuscular Modulation, and Wrinkle Reduction

Peer-reviewed References
Read Profile

GHK-Cu + Argireline + Leuphasyl (Trio)

Triple-Action Anti-Aging Complex, Targeting Matrix Renewal, Neuromuscular Modulation, and Wrinkle Reduction

Research Focus Areas
  • Extracellular Matrix Restoration
  • Expression Line Reduction
  • Antioxidant Defense Enhancement
  • Non-Invasive Topical Approach
Dosages in Published Literature
ProtocolApply 4-6 drops to cleansed skin once or twice daily
RouteTopical application
DurationMinimum 8-12 weeks for measurable results, ongoing use recommended
Read Profile
Topical
Longevity

Oligopeptide-34

Melanogenesis Modulator, Targeting Tyrosinase and MITF for Even Skin Tone

Peer-reviewed References
Read Profile

Oligopeptide-34

Melanogenesis Modulator, Targeting Tyrosinase and MITF for Even Skin Tone

Research Focus Areas
  • Multi-Level Melanogenesis Modulation
  • Non-Cytotoxic Mechanism
  • Comparable Efficacy to Established Agents
  • Broad Pigmentation Research Applications
Dosages in Published Literature
ProtocolApply 3-5 drops to cleansed target area twice daily
RouteTopical application
DurationMinimum 8-12 weeks for visible brightening effects
Read Profile
Pen
Body Composition

Semaglutide

GLP-1 Receptor Agonist, Precision Modulation of Appetite and Glycemic Regulation

Peer-reviewed References
Read Profile

Semaglutide

GLP-1 Receptor Agonist, Precision Modulation of Appetite and Glycemic Regulation

Research Focus Areas
  • Body Composition Modulation
  • Glycemic Regulation
  • Appetite & Satiety Modulation
  • Cardiovascular Risk Marker Improvement
Dosages in Published Literature
ProtocolDose titration starting at 0.25mg weekly
RouteSubcutaneous injection via auto-injector pen
DurationOngoing under specialist supervision, with periodic reassessment
Read Profile
Pen
Body Composition

Retatrutide

Triple Hormone Receptor Agonist, Simultaneous GIP/GLP-1/Glucagon Pathway Activation

Peer-reviewed References
Read Profile

Retatrutide

Triple Hormone Receptor Agonist, Simultaneous GIP/GLP-1/Glucagon Pathway Activation

Research Focus Areas
  • Superior Body Weight Reduction
  • Increased Energy Expenditure
  • Hepatic Fat Reduction
  • Comprehensive Cardiometabolic Improvement
Dosages in Published Literature
ProtocolDose titration starting at 0.5mg weekly
RouteSubcutaneous injection via auto-injector pen
DurationOngoing under specialist supervision with periodic reassessment
Read Profile
Pen
Body Composition

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist, Twincretin Technology for Metabolic Optimization

Peer-reviewed References
Read Profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist, Twincretin Technology for Metabolic Optimization

Research Focus Areas
  • Dual Pathway Glycemic Control
  • Significant Body Composition Effects
  • Favorable Fat Distribution Modulation
  • Hepatic & Cardiovascular Marker Improvement
Dosages in Published Literature
ProtocolDose titration starting at 2.5mg weekly
RouteSubcutaneous injection via auto-injector pen
DurationOngoing under specialist supervision with periodic reassessment
Read Profile
Pen
Longevity

NAD+

Essential Coenzyme, Direct Cellular Energy and DNA Repair Substrate Replenishment

Peer-reviewed References
Read Profile

NAD+

Essential Coenzyme, Direct Cellular Energy and DNA Repair Substrate Replenishment

Research Focus Areas
  • Cellular Energy Metabolism Support
  • Sirtuin-Mediated Longevity Pathway Activation
  • DNA Repair Capacity Enhancement
  • Neuroprotective & Cognitive Support
Dosages in Published Literature
Protocol100-250mg per administration
RouteSubcutaneous injection via auto-injector pen
DurationProtocols vary from acute loading phases (daily for 5-7 days) to maintenance schedules (1-3 times weekly). Duration determined by specialist assessment.
Read Profile
Pen
Longevity

SS-31 (Elamipretide)

Mitochondria-Targeted Peptide, Cardiolipin Stabilization for Electron Transport Optimization

Peer-reviewed References
Read Profile

SS-31 (Elamipretide)

Mitochondria-Targeted Peptide, Cardiolipin Stabilization for Electron Transport Optimization

Research Focus Areas
  • Mitochondrial Function Restoration
  • Oxidative Stress Reduction at Source
  • Cardioprotective Properties
  • Multi-Organ Cytoprotection
Dosages in Published Literature
Protocol0.25mg/kg per day administered subcutaneously
RouteSubcutaneous injection via auto-injector pen
DurationVariable based on indication and specialist assessment. Research protocols have studied durations from single dose to 8 weeks of daily administration.
Read Profile
Pen
Sexual Wellness

HCG

Gonadotropin Hormone, LH-Mimetic Signaling for Reproductive and Hormonal Research

Peer-reviewed References
Read Profile

HCG

Gonadotropin Hormone, LH-Mimetic Signaling for Reproductive and Hormonal Research

Research Focus Areas
  • Gonadal Function Preservation
  • Spermatogenesis Support
  • Hormonal Balance Maintenance
  • Reproductive Medicine Applications
Dosages in Published Literature
Protocol250-500 IU administered 2-3 times per week subcutaneously
RouteSubcutaneous injection via auto-injector pen
DurationDuration determined by clinical indication. Protocols range from short-term diagnostic uses to ongoing administration concurrent with hormonal therapy.
Read Profile
Pen
Body Composition

Somatropin (HGH)

Recombinant Human Growth Hormone, Direct Somatotropic Axis Supplementation

Peer-reviewed References
Read Profile

Somatropin (HGH)

Recombinant Human Growth Hormone, Direct Somatotropic Axis Supplementation

Research Focus Areas
  • Body Composition Optimization
  • Connective Tissue & Collagen Support
  • Bone Mineral Density Maintenance
  • Metabolic & Recovery Support
Dosages in Published Literature
Protocol1-4 IU per day administered subcutaneously
RouteSubcutaneous injection via auto-injector pen
DurationOngoing under specialist supervision with regular monitoring. Protocols typically reassess at 3-6 month intervals.
Read Profile
Blend Pen
Recovery

Glow Pen

Triple-Action Regenerative Blend, GHK-Cu + BPC-157 + TB-500 in a Single Auto-Injector

Peer-reviewed References
Read Profile

Glow Pen

Triple-Action Regenerative Blend, GHK-Cu + BPC-157 + TB-500 in a Single Auto-Injector

Research Focus Areas
  • Comprehensive Tissue Regeneration
  • Collagen Quality & Skin Rejuvenation
  • Balanced Anti-Inflammatory Support
  • Simplified Multi-Peptide Protocol
Dosages in Published Literature
ProtocolOne pen click per day
RouteSubcutaneous injection via auto-injector pen
Duration4-8 weeks per cycle, as determined by a your specialist
Read Profile
Blend Pen
Recovery

BT Blend Pen

Dual-Action Recovery Blend, BPC-157 + TB-500 in a Precision Auto-Injector

Peer-reviewed References
Read Profile

BT Blend Pen

Dual-Action Recovery Blend, BPC-157 + TB-500 in a Precision Auto-Injector

Research Focus Areas
  • Dual-Pathway Tissue Repair
  • Multi-Mechanism Anti-Inflammatory Action
  • Organized Tissue Architecture
  • Convenient Pre-Formulated Delivery
Dosages in Published Literature
ProtocolOne pen click per day
RouteSubcutaneous injection via auto-injector pen
Duration4-6 weeks per cycle, as determined by a your specialist
Read Profile
Blend Pen
Body Composition

CI Blend Pen

Synergistic Growth Hormone Optimization, CJC-1295 + Ipamorelin in a Precision Auto-Injector

Peer-reviewed References
Read Profile

CI Blend Pen

Synergistic Growth Hormone Optimization, CJC-1295 + Ipamorelin in a Precision Auto-Injector

Research Focus Areas
  • Synergistic Growth Hormone Optimization
  • Clean Selectivity Profile
  • Body Composition & Recovery Support
  • Precision Pen Delivery
Dosages in Published Literature
ProtocolOne pen click administered subcutaneously
RouteSubcutaneous injection via auto-injector pen
Duration8-12 weeks per cycle, as determined by a your specialist
Read Profile
Blend Pen
Body Composition

TCI Blend Pen

Triple-Action Growth Hormone Amplification, Tesamorelin + CJC-1295 + Ipamorelin in a Single Pen

Peer-reviewed References
Read Profile

TCI Blend Pen

Triple-Action Growth Hormone Amplification, Tesamorelin + CJC-1295 + Ipamorelin in a Single Pen

Research Focus Areas
  • Triple-Pathway Growth Hormone Optimization
  • FDA-Studied Tesamorelin Component
  • Selective Hormone Profile
  • Comprehensive Metabolic Support
Dosages in Published Literature
ProtocolOne pen click administered subcutaneously
RouteSubcutaneous injection via auto-injector pen
Duration8-12 weeks per cycle, as determined by a your specialist
Read Profile
Longevity

Sermorelin

Growth Hormone-Releasing Hormone Analogue, Restoring Natural GH Pulsatility

Peer-reviewed References
Read Profile

Sermorelin

Growth Hormone-Releasing Hormone Analogue, Restoring Natural GH Pulsatility

Research Focus Areas
  • Natural GH Pattern Restoration
  • Body Composition Improvement
  • Sleep Quality Enhancement
  • Anti-Aging & Recovery Support
Dosages in Published Literature
Protocol200-300mcg per day
RouteSubcutaneous injection
Duration3-6 months per cycle
Read Profile
Body Composition

Cagrilintide

Long-Acting Amylin Analogue, Next-Generation Appetite and Metabolic Regulation

Peer-reviewed References
Read Profile

Cagrilintide

Long-Acting Amylin Analogue, Next-Generation Appetite and Metabolic Regulation

Research Focus Areas
  • Clinically Significant Weight Reduction
  • Novel Appetite Regulation Pathway
  • Improved Glycemic Control
  • Convenient Once-Weekly Dosing
Dosages in Published Literature
Protocol0.25-2.4mg once weekly
RouteSubcutaneous injection
DurationOngoing under specialist supervision
Read Profile

Analytically Verified

HPLC & mass spectrometry tested

Video Consultations

Specialist guidance via video call

COA Available

Certificate of Analysis per lot

Expert Support

Protocol guidance from specialists

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.